We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

49 hedge funds and large institutions have $68.5M invested in Marrone Bio Innovations, Inc. in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $69.1M → $68.5M (-$596K)

8% less funds holding

Funds holding: 53 → 49 (-4)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EIM
Essex Investment Management
Massachusetts
+$868K
2
N
Nuveen
North Carolina
+$198K
3
FC
Fairpointe Capital
Illinois
+$155K
4
Millennium Management
Millennium Management
New York
+$92.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$92.1K

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$215K
2
State Street
State Street
Massachusetts
-$54.6K
3
ECM
ExodusPoint Capital Management
New York
-$49K
4
SIM
Spark Investment Management
New York
-$43.8K
5
Deutsche Bank
Deutsche Bank
Germany
-$38.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$37.1M – – –
AAP
2
Ardsley Advisory Partners
Connecticut
$13.5M – – –
BlackRock
3
BlackRock
New York
$3.99M +$34.4K +22,254 +0.8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.98M -$13.9K -8,989 -0.3%
Primecap Management
5
Primecap Management
California
$3.72M -$215K -138,890 -5%
State Street
6
State Street
Massachusetts
$1.17M -$54.6K -35,292 -4%
EIM
7
Essex Investment Management
Massachusetts
$843K +$868K +561,702 New
Northern Trust
8
Northern Trust
Illinois
$813K +$4.95K +3,200 +0.6%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$792K +$92.1K +59,543 +13%
FC
10
Fairpointe Capital
Illinois
$436K +$155K +100,000 +52%
IAM
11
ICM Asset Management
Washington
$388K – – –
Charles Schwab
12
Charles Schwab
California
$195K – – –
N
13
Nuveen
North Carolina
$192K +$198K +127,989 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$170K -$3.13K -2,022 -2%
California State Teachers Retirement System (CalSTRS)
15
California State Teachers Retirement System (CalSTRS)
California
$125K – – –
Wells Fargo
16
Wells Fargo
California
$111K -$8.43K -5,455 -7%
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
$105K +$4.47K +2,890 +4%
SIM
18
Spark Investment Management
New York
$100K -$43.8K -28,300 -30%
Millennium Management
19
Millennium Management
New York
$90K +$92.3K +59,682 New
RJA
20
Raymond James & Associates
Florida
$81K +$41.7K +26,957 +100%
Deutsche Bank
21
Deutsche Bank
Germany
$63K -$38.8K -25,107 -37%
SG Americas Securities
22
SG Americas Securities
New York
$59K -$14.1K -9,110 -19%
Barclays
23
Barclays
United Kingdom
$50K +$28.2K +18,215 +118%
AIG
24
American International Group
New York
$49K -$2.78K -1,797 -5%
VOYA Investment Management
25
VOYA Investment Management
Georgia
$49K – – –
1
2 3

MBII Hedge Fund Activity: Q2 2019 in Review

49 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2019, worth a combined $68.5M — down 0.86% from $69.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MBII and 7 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $868K. The largest seller was Primecap Management, cutting an estimated $215K.

  • 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2019, down from 53 in Q1 2019.
  • Funds reported $68.5M of Marrone Bio Innovations, Inc. stock for Q2 2019, down 0.86% quarter-over-quarter.
  • 7 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2019 and 9 closed out, a net change of -2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2019 was Essex Investment Management, an estimated $868K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2019 was Primecap Management, an estimated $215K sold.

Based on aggregated 13F filings for Q2 2019.